IMA compared with QTTB: revenue, margins and what each company keeps, and the suppliers and customers both name

IMAImageneBio, Inc.

Mkt capRevenueRevenue

QTTBQ32 Bio Inc.

Mkt capRevenueRevenue

Compare

IMAImageneBio, Inc.

QTTBQ32 Bio Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMA: latest quarter is a loss; flow not drawable. QTTB: latest quarter not drawable.Method ›

Price

rebased to 0%

IMA, solidQTTB, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMA 3

—Hutchmedunlistedsupplier

—Wuxi Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

Shared 0

No shared counterparties.

Only QTTB 6

BMYBristol-Myers Squibb Company ("BMS")supplier

AKBAAkebia Therapeutics, Inc. ("Akebia")customer

—The Regents of the University of Colorado ("Colorado")unlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Horizon Therapeutics Ireland DAC

unlistedsupplier

2 more · QTTB chain ›

IMAImageneBio, Inc.

4.15▲+2.47%· post 4.15

Mkt cap$46.5MRevenue$800,000Q4 FY25

QTTBQ32 Bio Inc.

8.91▲+0.47%· post 9.00

ClosedOct 30 '26

Mkt cap$265.2MRevenue$54MQ4 FY25

Compare

ClosedOct 30 '26

IMAImageneBio, Inc.

QTTBQ32 Bio Inc.

4.15▲+2.47%post 4.15

Price

8.91▲+0.47%post 9.00

$46.5M

Mkt cap

$265.2M

Q4 FY25$800,000

Revenue

$54MQ4 FY25

IMA4.15▲+2.47%vsQTTB8.91▲+0.47%ClosedOct 30 '26